RemeGen Co

RemeGen Co EPS

The Earnings per Share (EPS) of RemeGen Co (688331.SS) as of Oct 26, 2026 is 1.29 CNY. In the previous year, Earnings per Share (EPS) was -2.74 CNY — a change of -147.26% (higher).

EPS

1.29CNY

YoY

-147.26%

Last updated:

Earnings per Share (EPS) of RemeGen Co is 2025 1.29 CNY. Earnings per Share (EPS) of RemeGen Co was 2024 -2.74 CNY. It decreases by -147.26% higher compared to the previous year.

The RemeGen Co EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2021
0.57 CNY
Jan 1, 2022
-1.78 CNY
Jan 1, 2023
-2.80 CNY
Jan 1, 2024
-2.74 CNY
Jan 1, 2025
1.29 CNY
Jan 1, 2027 (e)
1.41 CNY
Jan 1, 2028 (e)
2.49 CNY
Jan 1, 2029 (e)
7.27 CNY
The RemeGen Co EPS history
YEAREPSYoY
est7.27CNY+192.18%
est2.49CNY+75.75%
est1.41CNY+9.33%
1.29CNY-147.26%
-2.74CNY-2.12%
-2.80CNY+57.14%
-1.78CNY-412.81%
0.57CNY-139.95%
-1.42CNY+58.38%
-0.90CNY+82.43%
-0.49CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RemeGen Co Stock analysis

What does RemeGen Co do? RemeGen Co Ltd generates revenue by researching, developing, and manufacturing innovative biopharmaceuticals, specifically focusing on therapeutic antibody drugs. The company's product portfolio includes tetacept (RC18), veldicitumab (RC48), and a dual-target fusion protein (RC28). These products are designed to treat major diseases such as oncology, autoimmune diseases, and ophthalmology. The firm operates primarily in the domestic market within China, where it commercializes its discoveries. Its business model relies on the development of various antibody types, including antibody drug conjugates (ADCs), antibody fusion proteins, monoclonal antibodies, and bispecific antibodies. This focus allows the company to address significant medical needs through its specialized therapeutic offerings. RemeGen Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RemeGen Co stock

Earnings per Share (EPS) of RemeGen Co is 1.29 CNY in 2025.

Earnings per Share (EPS) of RemeGen Co changed from -2.74 CNY to 1.29 CNY, representing a -147.26% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) RemeGen Co since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — RemeGen Co

All Key Metrics — RemeGen Co